Preclinical/Phase I

A product in early development needs the right communications activities to inform the direction of research and establish early credentials with key stakeholders. We’ll help with scoping the key features, possible claims and long-range competitive landscape. We’ll also begin early publication activity, securing the interest and attention of researchers and doctors.

Our tasks in this stage are both scientific and strategic. Scientific, because we’ll be dealing with highly technical research characterizing the product. Strategic, because decisions made now, and perceptions formed, will profoundly shape the product’s future direction. It’s essential to create a strategic overview through effective communications planning; a core activity that will continue throughout the life of the product. With our strong scientific credentials, we are well placed to understand the basic and applied science behind a product, to interact with the researchers working on its early development and to translate their vision into commercial potential.

In a publication planning program, we’ll also ensure timely and appropriate exposure of key product features and can also begin to communicate class messages. We have extensive experience in preparing such materials and in supporting researchers in their communications activities in preclinical and early development products. Our writers have direct experience of biopharmaceutical research ranging from molecular biology through experimental psychology to medical devices.